Compare Gilead Sciences, Inc. (GILD) vs International Business Machines Corp (IBM) Price & Performance

Gilead Sciences, Inc.Trade

International Business Machines CorpTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs International Business Machines Corp — how do they compare? Gilead Sciences, Inc. trades at $135.5 (market cap $168.35B), while International Business Machines Corp trades at $237.7 (market cap $224.62B). The key difference: International Business Machines Corp is the larger of the two by market cap, and International Business Machines Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.

	GILD	IBM
Market Cap	$168.35B	$224.62B
Sector	Health	Technology
52-Week High	$155.80	$329.23
52-Week Low	$110.56	$205.77
Enterprise Value	$191.42B	$281.76B
Dividend Yield	2.42%	2.84%
Volume	—	4,481,527

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GILD

Gilead upgrades 2026 sales outlook as HIV drug Biktarvy and Livdelzi show strong growthSeeking Alpha · 2 days agoBullish 2026 National ORBIE Awards honor top CIOs and CISOs across key industry categories in San Jose.Inspire Leadership Network · 4 days agoNeutral View details →

IBM

Big Tech plans $725B AI spend in 2026, but IBM warns revenue may not justify it.24/7 Wall Street · 1 day agoNeutral IBM and Together AI launch first large-scale NVIDIA HGX B300 AI inference cluster on IBM Cloud.PRNewsWire · 1 day agoBullish OpenAI expands Daybreak cyber defense with new GPT-5.6-Cyber model for advanced security tasksTechCrunch · 1 day agoBullish View details →

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.